Factors associated with superior antibody responses to a single dose of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine administered to Chilean infants at 2 months of age

Vaccine

Volumn 15, Issue 3, 1997, Pages 325-328

  Levine, Orin S ^a,f   Granofff, Dan M ^b,c   Lagos, Rosanna ^d   Fritzell, Bernard ^e,f   Levine, Myron M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d Ctro Para Vacunas en Desarollo C   (Chile)

^e Pasteur/Merieux Serums et Vaccins   (France)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

conjugate vaccines; Haemophilus influenzae; immunization

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; TETANUS TOXOID;

ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TETANUS;

ANTIBODIES, BACTERIAL; CHILE; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HAEMOPHILUS VACCINES; HUMANS; INFANT; TETANUS TOXOID; UNITED STATES; VACCINES, CONJUGATE;

EID: 0031043414     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00161-2     Document Type: Article

References (19)

1. Ferreccio, C., Clemens, J. and Avendano, A. et al. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus toxoid protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four, and six months of age. Pediatr. Infect. Dis. J. 1991, 10, 764-771
2. Clemens, J.D., Ferreccio, C. and Levine, M.M. et al. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. J. Am. Med. Assoc. 1992, 267, 673-678
3. Avendano, A., Ferreccio, C. and Lagos, R. et al. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus, or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age. Pediatr. Infect. Dis. J. 1993, 12, 638-643
4. Holmes, S.J., Fritzell, B. and Guito, K.P. et al. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants. Am. J. Dis. Child 1993, 147, 832-836
5. Watemberg, N., Dagan, R. and Arbelli, Y. et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr. Infect. Dis. J. 1991, 10, 758-761
6. Greenberg, D.P., Vadheim, C.M., Partridge, S., Chang, S.J., Chiu, C.Y. and Ward, J.I. Immunogenicity of Haemophilus influenzae type b tetanus toxoid conjugate vaccine in young infants. The Kaiser-UCLA Vaccine Study Group. J. Infect. Dis. 1994, 170, 76-81
7. Granoff, D.M., Anderson, E.L. and Osterholm, M.T. et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J. Pediatr. 1992, 121, 187-194
8. Bulkow, L.R., Wainwright, R.B., Letson, G.W., Chang, S.J. and Ward, J.I. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants. Pediatr. Infect. Dis. J. 1993, 12, 484-492
9. Granoff, D.M. and Lucas, A.H. Laboratory correlates of protection against Haemophilus influenzae type b disease. Impor-tance of assessment of antibody avidity and immunologic memory. Ann. N.Y. Acad. Sci. 1995, 754, 278-288
10. Granoff, D.M., Rathure, M.H., Granoff, P.D. and Lucas, A.H. Effect of immunity to the carrier protein on antibody response to Haemophilus influenzae type b conjugate vaccine. Vaccine 1993, 11, S46-S51
11. Granoff, D.M., Holmes, S.J. and Belshe, R.B. et al. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants. J. Am. Med. Assoc. 1994, 272, 1116-1121
12. Lieberman, J.M., Greenberg, D.P. and Wong, V.K. et al. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. J. Pediatr. 1995, 126, 198-205
13. Barington, T., Gyhrs, A., Kristensen, K. and Heilmann, C. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect. Immun. 1994, 62, 9-14
14. Castillo de Febres, O., Decker, M.D., Estopinan, M., Bordones, G. and Edwards, K.M. Enhanced antibody response in Venezuelan infants immunized with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatr. Infect. Dis. J. 1994, 13, 635-639
15. Parke, J.C. Jr, Schneerson, R. and Reimer, C. et al. Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7 and 18 months of age. J. Pediatr. 1991, 118, 184-190
16. Claesson, B.A., Schneerson, R. and Robbins, J.B. et al. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J. Pediatr. 1989, 114, 97-100
17. Robbins, J.B., Schneerson, R. and Pitman M. Haemophilus influenzae type b. In: Bacterial Vaccines (Ed Germanier, R.). Academic Press, New York, 1984, pp. 289-316
18. Schneerson, R. and Robbins, J.B. Induction of serum Haemophilus influenzae type b capsular antibodies in adult volunteers fed cross-reacting Escherichia coli O75:K100:H5. N. Engl. J. Med. 1975, 292, 1093-1096
19. Granoff, D.M. and Holmes, S.J. G2m(23) immunoglobulin allotype and immunity to Haemophilus influenzae type b. J. Infect. Dis. 1992, 165, S66-S69